BioLife Solutions, Inc.
BLFS
$20.12
-$0.55-2.66%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -11.77% | 10.41% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -11.77% | 10.41% | |||
| Cost of Revenue | -8.85% | 12.88% | |||
| Gross Profit | -13.42% | 9.05% | |||
| SG&A Expenses | -7.79% | 3.36% | |||
| Depreciation & Amortization | -90.56% | -1.27% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -11.76% | 6.08% | |||
| Operating Income | 10.11% | 92.07% | |||
| Income Before Tax | 175.25% | 104.47% | |||
| Income Tax Expenses | -310.98% | -34.92% | |||
| Earnings from Continuing Operations | 239.45% | 103.92% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 1,682.45% | 103.92% | |||
| EBIT | 10.11% | 92.07% | |||
| EBITDA | -59.39% | 379.23% | |||
| EPS Basic | 1,668.46% | 103.92% | |||
| Normalized Basic EPS | 172.83% | 468.00% | |||
| EPS Diluted | 2,128.00% | 103.02% | |||
| Normalized Diluted EPS | 174.44% | 460.00% | |||
| Average Basic Shares Outstanding | 0.46% | 0.27% | |||
| Average Diluted Shares Outstanding | 0.59% | 1.94% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||